Sens Stocktwits Stock Forecast & Price Target
Sens stocktwits a medical technology company, improves and markets constant glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Internal East, and Africa. The Company’s goods include Eversense and Eversense XL, which are implantable CGM systems for measuring glucose levels in people with diabetes via a subcutaneous device, an attached and rechargeable bright source, and a convenient app for real-time diabetes monitoring and management for up to six months. It serves healthcare providers and patients through distributors and strategic compliance partners.
Senseonics Holdings (SENS) Stock Forecast & Price Target
Price Target
Sens stocktwits Based on short-term target prices offered by three analysts, the average target price for Essenics Holdings is $1.60. Forecasts range from a low of $0.30 to a high of $2.50. The regular target price represents an increase of 290.24% from the last closing price of $0.41.
Broker Rating
Senseonics Holdings currently has an average brokerage approval (ABR) of 2.80 on a scale of 1 to 5 (strong buy to solid sell), calculated based on actual recommendations (buy, hold, sell, etc.) made by five brokerage firms. Based on five recommendations, the current ABR compares to an ABR of 2.80 one month ago.
Two of the five recommendations from the current ABR are strong buys, representing 40% of all recommendations. One month ago, a strong buy represented 40% of the total.
Trading Expectations (SENS) For The Upcoming Trading Day
For the upcoming trading day on Monday, the 19th, we expect Senseonics Holdings Inc to open at $0.409 and during the day to move between $0.388 and $0.438, which gives a possible trading interval of +/-$0.0251 (+/-6.08%) up or down from last closing price. If Senseonics Holdings Inc. takes out the fully designed possible swing range, there will be an estimated 12.15% move between the lowest and the highest trading price in the day.
Since the stock is closer to the support from the collected volume at $0.410 (0.68%) than the resistance at $0.440 (6.59%), our systems see the trading risk/return intra-day as attractive and accept that actual profit can be made before the stock reaches first resistance.
Recently Viewed
| Symbol | Name | Last Price | Market Time | Change | % Change | Volume | Market Cap |
| SENS | Senseonics Holdings, Inc. | 0.4128 | 4:00PM EDT | 0.0008 | 0.19% | 7,41,854 | 221.085M |
| ATNM | Actinium Pharmaceuticals, Inc. | 1.82 | 4:00PM EDT | -0.13 | -6.67% | 1.294M | 56.701M |
| GOES | Canoo Inc. | 1.5 | 4:00PM EDT | -0.04 | -2.60% | 2.472M | 116.834M |
| ICU | SeaStar Medical Holding Corporation | 6.51 | 4:00 PM EDT | 0.33 | 5.34% | 1,36,714 | 27.14M |
| MULN | Mullen Automotive, Inc. | 0.2716 | 4:00PM EDT | -0.0692 | -20.31% | 37.643M | 10.902M |
SENS Financial Forecast
Sens stocktwits Earnings Forecast
Next quarter’s earnings estimate for SENS is -$0.03 with a range of -$0.03 to -$0.03. The previous quarter’s EPS was -$0.03. SENS beat its EPS assessment 25.00% of the time in the past 12 months, while its overall industry tired the EPS estimation of 57.30% in the same period. In the last calendar year, SENS has Underperformed its overall sector.
SENS Sales Forecast
Next quarter’s sales forecast for SENS is $4.93M, ranging from $4.60M to $5.15M. The previous quarter’s sales results were $5.05M. SENS beat its sales estimates 75.00% of the time in the past 12 months, while its overall industry weary sales estimations were 46.68% in the same period. In the last calendar year, SENS has Outperformed its overall industry.